[Attacks of gout and thromboembolic disease: role of heparin therapy].
The authors report 4 cases of acute gout in the lower limb occurring soon after starting heparin therapy for venous thromboembolic disease. As none of the usual factors which induce gout were present, the possible roles of the venous thrombosis and the heparin therapy were examined. Intra-articular thermic and acid-base changes secondary to the thrombosis could have explained the site of the attacks of gout in 3 of our 4 patients; the fourth patient had normal phlebography; the relationship between the attack and the start of heparin therapy suggested that the heparin may have induced the gout, possibly by an interaction with the synovial proteoglycans leading to the precipitation of urate crystals in the joint. In the absence of references in the literature, these hypotheses need further confirmation.
D000208:Acute Disease; D000368:Aged; D001168:Arthritis / Q000139:chemically induced*; D005260:Female; D006073:Gout / Q000139:chemically induced* / Q000503:physiopathology; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000188:drug therapy*; D014527:Uric Acid / Q000378:metabolism
D014527:Uric Acid; D006493:Heparin
Crise de goutte et maladie thrombo-embolique: rôle de l'héparinothérapie.